基因多态性预测了巴林状细胞病患者对氧尿素治疗的反应
Fatimah S Alshaikh1, Abdelhalim Deifalla2, Reginald P Sequeira3
1College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Bahrain.
Expert review of hematology
|August 9, 2025
概括
氧尿素治疗通过增加胎儿血红蛋白 (HbF) 来改善状细胞疾病的结果. 遗传因素影响患者的反应,这表明需要个性化治疗策略.
科学领域:
- 血液学 血液学 血液学
- 药物基因组学 药物基因组学
- 遗传学 是一个遗传学.
背景情况:
- 状细胞疾病 (SCD) 是一种遗传性血液疾病,其特征是血红蛋白异常.
- 水氧尿素 (HU) 是一种旨在增加胎儿血红蛋白 (HbF) 以减轻SCD并发症的治疗方法.
- 了解影响HU响应的因素对于优化SCD管理至关重要.
研究的目的:
- 调查氧尿素 (HU) 治疗反应与状细胞病 (SCD) 患者胎儿血红蛋白 (HbF) 水平之间的关联.
- 确定影响HbF合成,药物运输和SCD患者新陈代谢的基因突变的患病率.
- 为了将遗传变异与对HU治疗的不同反应相关联.
主要方法:
- 研究了390名巴林患者的队列,这些患者有状细胞危机史.
- 患者被分为响应者 (HbF ≥15%和临床改善) 和非响应者.
- 进行基因型鉴定,以确定特定基因 (ARG2,HBS1L-MYB,CYP2C19,OATP1B3) 的小等位基因频率.
主要成果:
- 水氧尿素治疗导致疼痛危机,住院和白细胞数量减少,Hb和HbF水平增加.
- 非响应者对ARG2,HBS1L-MYB,CYP2C19和OATP1B3基因的小等位基因的频率明显更高.
- 在HbF水平和每年疼痛危机和住院治疗的频率之间观察到负相关性.
结论:
- 调节HbF合成和药物代谢的基因的遗传变异会影响SCD患者的基尿素反应.
- 考虑到个体遗传特征的个性化治疗方法对于最大限度地提高HU的益处并最大限度地减少不良影响至关重要.
- 基于药物遗传学见解的优化HU治疗可以改善状细胞病患者的临床结果.
相关概念视频
Multiple Allele Traits
34.9K
The Concept of Multiple Allelism
34.9K
Genome-wide Association Studies-GWAS
14.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.2K
Translation
143.4K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
143.4K
Genetic Variation
388
Genetic variation is the diversity in DNA sequences found among individuals of the same species. This diversity is crucial for a species' survival because it helps organisms adapt to environmental changes. Genetic variation begins with fertilization, where an egg and sperm cell merge. Each of these cells carries 23 chromosomes, up to 46 in the fertilized egg. Chromosomes are long DNA strands that contain genes, the basic units of heredity.
Genes exist in different versions called alleles,...
Genes exist in different versions called alleles,...
388
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
257
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
257
Genetic Lingo
104.7K
Overview
104.7K


